Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 3, 2014New England Journal of MedicineOpen Access

A Molecular Basis for Nicotine as a Gateway Drug

View Full Paper
Ask AI
Bookmark
Share

Authors

Eric R. Kandel
Eric R. KandelCity College of New YorkDKDenise B. KandelColumbia University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kandel et al. (2014) studied this question.

synapsesocial.com/papers/69fbd8496c3a0c248625deefhttps://doi.org/10.1056/nejmsa1405092
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular Mechanism for a Gateway Drug: Epigenetic Changes Initiated by Nicotine Prime Gene Expression by Cocaine2011 · 285 citations
  2. 2Stages and Pathways of Drug Involvement: Examining The Gateway Hypothesis2002 · 363 citations
  3. 3The emerging phenomenon of electronic cigarettes2012 · 207 citations
  4. 4Genetic and Environmental Influences on Substance Initiation, Use, and Problem Use in Adolescents2003 · 393 citations
  5. 5Regulate e-cigarettes as drug-delivery devices2013 · 9 citations